. Author manuscript; available in PMC: 2020 Nov 7.

Published in final edited form as: Int J Dermatol. 2020 Feb 28;59(9):1033–1042. doi: 10.1111/ijd.14824

Table 3.

Number of human studies about the association between maternal prenatal urinary concentration of oxybenzone (BP-3) or octinoxate (OMC) and the target effects in child. n=13 (duplicate excluded)

Target effect	Statistically significant association		No statistically significant association
	BP-3	OMC	BP-3	OMC
Offspring's birth weight	1 (↑ in boys)	0	4	0
Offspring's birth defect	1 (↑)	0	1	0
Offspring's allergic outcome	1 (↓)	0	0	0
Offspring's pubertal onset	0	0	1	0
Offspring's body fat mass	0	0	1	0
Offspring's intelligence quotient (IQ)	0	0	1	0
Offspring's behavior	0	0	1	0
Offspring's sex determination	0	0	1	0

In parenthesis, ↓ indicates a negative correlation with elevated BP-3 level. ↑ indicates a positive correlation with elevated BP-3 level.